Agios Pharmaceuticals Inc at RBC Capital Markets Global Healthcare Conference Transcript
Thanks. Hello, everybody. Luca Issi, Senior Biotech Analyst here at RBC Capital Market and today is our great privilege to have Agios as part of our 2026 RBC Global Healthcare Conference. Representing the company here, we have the whole team here.
So Brian Goff, Chief Executive Officer, Sarah Gheuens, Chief Medical Officer, as well as Tsveta Milanova, Chief Commercial Officer. So, thanks again, guys, for joining. How are you doing?
Very well. Thanks a lot for hosting us.
Questions & Answers
Good. We have a long list of questions here, but maybe before we go into specifics and ask about SDA correspondence and conversations, maybe Brian would be fantastic if you can start a little bit big picture, talk about what progress has the organization made over the last few months, and maybe most importantly, what's ahead here for Agios'.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
